Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Gains from Investment Securities (2017 - 2025)

Puma Biotechnology's Gains from Investment Securities history spans 9 years, with the latest figure at $197000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 144.47% year-over-year to $197000.0; the TTM value through Dec 2025 reached -$246000.0, up 44.59%, while the annual FY2025 figure was $3.7 million, 9.45% down from the prior year.
  • Gains from Investment Securities reached $197000.0 in Q4 2025 per PBYI's latest filing, up from $84954.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.0 million in Q2 2025 to a low of -$443000.0 in Q4 2024.
  • Average Gains from Investment Securities over 5 years is $457989.9, with a median of $441430.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: crashed 101.54% in 2021, then skyrocketed 58335.3% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at -$1000.0 in 2021, then surged by 58335.3% to $582353.0 in 2022, then dropped by 0.13% to $581614.0 in 2023, then plummeted by 176.17% to -$443000.0 in 2024, then skyrocketed by 144.47% to $197000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBYI's Gains from Investment Securities are $197000.0 (Q4 2025), $84954.0 (Q3 2025), and $3.0 million (Q2 2025).